Affimed NV News - AFMD

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Affimed NV AFMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.06 -3.66% 1.58 1.55 1.70 1.68 1.64 18:43:39
more quote information »

Recent News

Date Time Source Heading
4/02/202006:30GLOBEAffimed Provides COVID-19-Related Business Update and..
4/01/202016:01GLOBEAffimed Announces FDA Granted Orphan Drug Designation for..
3/26/202007:30GLOBEAffimed Announces Participation at Upcoming Virtual Investor..
3/17/202007:30GLOBEAffimed Announces Appointment of Arndt Schottelius, M.D...
2/19/202007:30GLOBEAffimed to Present at the SVB Leerink 9th Annual Global..
2/13/202016:19EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202008:51EDGARStatement of Ownership (sc 13g)
2/03/202007:38EDGARReport of Foreign Issuer (6-k)
2/03/202007:30GLOBEAffimed Mourns Passing of Chief Financial Officer Dr...
1/10/202006:30GLOBEAffimed Announces Appointment of Andreas Harstrick, M.D., as..
12/17/201907:30GLOBEAffimed Announces Addition to NASDAQ Biotechnology Index
11/19/201907:30GLOBEAffimed Reports Third Quarter 2019 Financial Results and..
11/14/201906:30GLOBEAffimed to Present at the Jefferies 2019 London Healthcare..
11/13/201916:10GLOBEAffimed Announces Closing of Public Offering of Common..
11/12/201916:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/08/201906:30GLOBEAffimed Announces Pricing of Public Offering of Common..
11/07/201917:12EDGARReport of Foreign Issuer (6-k)
11/07/201917:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/07/201916:11GLOBEAffimed Announces Proposed Public Offering of Common Shares
11/07/201916:01GLOBEAffimed Highlights Progress on NK Cell Engager Collaboration..
10/15/201906:30GLOBEAffimed Reports Progress on Key Clinical Development..
8/28/201905:00GLOBEAffimed to Participate in Investor Conferences in September
8/07/201908:24EDGARReport of Foreign Issuer (6-k)
8/07/201907:30GLOBEAffimed Reports Second Quarter 2019 Financial and..
7/31/201905:00GLOBEAffimed Announces Second Quarter 2019 Financial Results and..
7/01/201905:00GLOBEAffimed Added to the Russell 2000®, 3000® and Microcap..
6/27/201916:20EDGARReport of Foreign Issuer (6-k)
6/24/201905:00GLOBEAffimed Announces Clinical Data Update on Lead Product..
6/12/201905:30GLOBEAffimed to Present Data on AFM13 at the 15th International..
6/04/201916:18EDGARReport of Foreign Issuer (6-k)
6/04/201916:01GLOBEAffimed Announces Annual General Meeting of Shareholders
6/03/201905:00GLOBEIcosagen and AbCheck Announce Five-year Licensing Agreement..
5/29/201905:00GLOBEAffimed to Present at the Jefferies 2019 Healthcare..
5/22/201907:38EDGARReport of Foreign Issuer (6-k)
5/22/201907:30GLOBEAffimed Announces R&D Strategy to Focus on Innate Immunity..
5/16/201905:00GLOBEAffimed Announces First Quarter 2019 Financial Results and..
4/17/201916:12EDGARReport of Foreign Issuer (6-k)
4/17/201916:05GLOBEAffimed Provides Regulatory Update on AFM11 Clinical Program
4/11/201916:36EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/09/201907:49EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/05/201916:10EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
See more news about this stock »


Your Recent History
NASDAQ
AFMD
Affimed NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.